Cargando…
Baseline Prediction of Combination Therapy Outcome in Hepatitis C Virus 1b Infected Patients by Discriminant Analysis Using Viral and Host Factors
BACKGROUND: Current treatment of chronic hepatitis C virus (HCV) infection has limited efficacy −especially among genotype 1 infected patients−, is costly, and involves severe side effects. Thus, predicting non-response is of major interest for both patient wellbeing and health care expense. At pres...
Autores principales: | Saludes, Verónica, Bracho, Maria Alma, Valero, Oliver, Ardèvol, Mercè, Planas, Ramón, González-Candelas, Fernando, Ausina, Vicente, Martró, Elisa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994723/ https://www.ncbi.nlm.nih.gov/pubmed/21152430 http://dx.doi.org/10.1371/journal.pone.0014132 |
Ejemplares similares
-
Relevance of Baseline Viral Genetic Heterogeneity and Host Factors for Treatment Outcome Prediction in Hepatitis C Virus 1b-Infected Patients
por: Saludes, Verónica, et al.
Publicado: (2013) -
Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses
por: Bracho, Maria A, et al.
Publicado: (2008) -
Effect of oligonucleotide primers in determining viral variability within hosts
por: Bracho, Maria Alma, et al.
Publicado: (2004) -
La espectrometría de masas en el laboratorio de microbiología clínica
por: Jordana-Lluch, Elena, et al.
Publicado: (2012) -
Incidence and molecular epidemiology of hepatitis C virus reinfection in prisons in Catalonia, Spain (Re-HCV study)
por: Saludes, Verónica, et al.
Publicado: (2023)